MedPath

Examination of the remission maintenance effect by low dose etanercept after clinical remission in the rheumatoid arthritis.

Not Applicable
Conditions
Rheumatoid Arthritis
Registration Number
JPRN-UMIN000013362
Lead Sponsor
Takarazuka city hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Patient with a history of the use of the preparation biological by temporary registration. The patient who does not correspond to adaptation of the biologics.

Study & Design

Study Type
Interventional,observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Remission maintenance rate (DAS28,SDAI,CDAI) SJC,TJC,CRP,MMP-3,RF,ESR
Secondary Outcome Measures
NameTimeMethod
Funtional remission rate (HAQ,EQ5D) Radiographic remission rate(mTSS)
© Copyright 2025. All Rights Reserved by MedPath